fda warning letters compounded semaglutide tirzepatide 2025 The has received reports of adverse events after patients used versions of semaglutide. Some compounders may also be using unapproved salt forms. Patients should avoid compounded when an FDA-approved FDA warns against compounded versions

NAFLD is a progressive disease that is characterized by hepatic insulin resistance and inflammation associated with fat accumulation in the liver (Figure 2)

Its easier than you might think

Convenient to take with you to work, school, long flights, cruises, sports activities, and everyday outings

The tingling, numbness, and pain in extremities significantly impacts quality of life, and current treatments offer limited relief because they don't address underlying nerve damage

While A1C control matters for preventing microvascular complications (eye, kidney, nerve damage), cardiovascular events represent the leading cause of death in diabetes